GDRX Key Statistics, Chart & Performance
The current stock price of GDRX is 2.8 USD. In the past month the price increased by 0.36%. In the past year, price decreased by -38.46%.
GDRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31.02 | 39.47B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.7 | 8.24B | ||
| WAY | WAYSTAR HOLDING CORP | 25.75 | 6.60B | ||
| HTFL | HEARTFLOW INC | N/A | 2.82B | ||
| CERT | CERTARA INC | 18.66 | 1.49B | ||
| SDGR | SCHRODINGER INC | N/A | 1.35B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 646.5 | 1.10B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| PHR | PHREESIA INC | N/A | 1.03B | ||
| HSTM | HEALTHSTREAM INC | 32.5 | 655.71M | ||
| CTEV | CLARITEV CORP | N/A | 478.38M |
Related stock screener links
About GDRX
Company Profile
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 738 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
Company Info
GOODRX HOLDINGS INC-CLASS A
2701 Olympic Boulevard
Santa Monica CALIFORNIA 90404 US
CEO: Douglas Hirsch
Employees: 738
Phone: 18552682822
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you describe the business of GOODRX HOLDINGS INC-CLASS A?
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 738 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
What is the current price of GDRX stock?
The current stock price of GDRX is 2.8 USD. The price increased by 0.36% in the last trading session.
Does GDRX stock pay dividends?
GDRX does not pay a dividend.
How is the ChartMill rating for GOODRX HOLDINGS INC-CLASS A?
GDRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the ownership details for GDRX stock?
You can find the ownership structure of GOODRX HOLDINGS INC-CLASS A (GDRX) on the Ownership tab.
Can you provide the short interest for GDRX stock?
The outstanding short interest for GOODRX HOLDINGS INC-CLASS A (GDRX) is 8.84% of its float.
GDRX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GDRX. When comparing the yearly performance of all stocks, GDRX is a bad performer in the overall market: 91.77% of all stocks are doing better.
GDRX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GDRX. GDRX has only an average score on both its financial health and profitability.
GDRX Financial Highlights
Over the last trailing twelve months GDRX reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS increased by 9.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.97% | ||
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| Debt/Equity | 0.81 |
GDRX Forecast & Estimates
21 analysts have analysed GDRX and the average price target is 4.98 USD. This implies a price increase of 77.89% is expected in the next year compared to the current price of 2.8.
For the next year, analysts expect an EPS growth of 11.45% and a revenue growth 0.19% for GDRX